$207 Million is the total value of ARCH Venture Management, LLC's 8 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 25.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EQRX, INC. | $70,490,628 | -21.1% | 36,335,375 | 0.0% | 34.02% | +48.6% | ||
DNLI | Sell | DENALI THERAPEUTICS, INC. | $59,183,977 | -42.0% | 2,568,749 | -30.0% | 28.57% | +9.3% |
ERASCA, INC. | $33,277,218 | -30.2% | 11,055,554 | 0.0% | 16.06% | +31.6% | ||
VERV | VERVE THERAPEUTICS, INC. | $28,967,026 | -25.5% | 2,008,809 | 0.0% | 13.98% | +40.4% | |
KRTX | Sell | KARUNA THERAPEUTICS, INC. | $5,449,200 | -94.6% | 30,000 | -94.2% | 2.63% | -89.8% |
OMIC | SINGULAR GENOMICS SYSTEMS, INC. | $4,596,700 | -39.8% | 3,798,926 | 0.0% | 2.22% | +13.4% | |
NTRA | New | NATERA, INC. | $3,577,764 | – | 64,441 | +100.0% | 1.73% | – |
UNITY BIOTECHNOLOGY, INC. | $1,637,852 | -40.5% | 1,004,817 | 0.0% | 0.79% | +12.2% | ||
MTCR | Exit | METACRINE, INC. | $0 | – | -2,940,503 | -100.0% | -0.34% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
RUBIUS THERAPEUTICS, INC. | 12 | Q3 2022 | 65.5% |
EQRX, INC. | 8 | Q3 2023 | 52.4% |
ERASCA, INC. | 8 | Q3 2023 | 18.8% |
VERVE THERAPEUTICS, INC. | 8 | Q3 2023 | 23.3% |
CHIASMA INC | 8 | Q3 2020 | 25.7% |
SINGULAR GENOMICS SYSTEMS, INC. | 8 | Q3 2023 | 4.6% |
KURA ONCOLOGY INC | 7 | Q2 2020 | 27.6% |
KARUNA THERAPEUTICS, INC. | 6 | Q1 2023 | 52.8% |
DENALI THERAPEUTICS, INC. | 6 | Q3 2023 | 28.6% |
SYROS PHARMACEUTICALS INC | 5 | Q3 2020 | 43.8% |
View ARCH Venture Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-15 |
13F-HR/A | 2022-05-27 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-14 |
View ARCH Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.